agilon health Chief Experience & Innovation Officer Lisa Dombro to resign effective Feb 28, 2022

agilon health, inc.

Lisa Dombro resigns as Chief Experience & Innovation Officer effective February 28, 2022.
Resignation is to pursue another career opportunity; not due to any disagreement with the company.
No successor or interim appointment announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lisa Dombro

Chief Experience & Innovation Officer

AGL · agilon health, inc.

Effective: 2022-02-28
Filed: February 14, 2022, 6:59 PM ET

Effective February 28, 2022, Lisa Dombro will resign as Chief Experience & Innovation Officer of agilon health, inc. (the “Company”) to pursue another career opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lisa Dombro resigned as Chief Experience & Innovation Officer at agilon health, inc..

Action: resigned
Role: Chief Experience & Innovation Officer

Exact text from the filing

Effective February 28, 2022, Lisa Dombro will resign as Chief Experience & Innovation Officer of agilon health, inc. (the “Company”) to pursue another career opportunity.

View on SEC.gov

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-001164

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.